Blueprint Medicines Corp

📅 Upcoming

🕒 Recent(90d)

News

• Trend of women-led M&A fades in 2026 with just two deals so far
  Last year, 11 major M&A deals were signed with women-led biotechs. The industry is nowhere near on track to meet that bar for 2026.
  biospace · 3d ago
• Biopharma recruiters see ‘signs of recovery’ as layoffs remain cool in Q3’26
  A more subdued volume of biopharma layoffs continued into the third quarter of 2026, validating predictions that the sector has moved beyond the avalanche of redundancies experienced last year.
  fiercebiotech · 4d ago
• August biopharma layoffs impact just over 500, down 90% year over year
  Last month, biotech and pharma companies making or planning workforce cuts included three whose reductions will more than halve their workforces. Blueprint Medicines’ layoffs will affect the most e…
  biospace · 23d ago
• Solstice rises with $225M to develop next-gen CTLA-4 drug from China
  Solstice Oncology, founded in February, is emerging from stealth having already secured an investigational new drug application from the FDA for a Phase 2 trial of a CTLA-4 antibody purchased from…
  biospace · 24d ago
• After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platform
  After announcing the “tough but necessary” decision to lay off some employees last year, Frontier Medicines is looking to the future by advancing more cancer drugs into the clinic while continuing…
  fiercebiotech · 1mo ago
• 7 biopharma M&A deals where layoffs followed
  Workforce cuts this year at seven companies involved in recent mergers and acquisitions will cost over 1,300 employees their jobs. Affected businesses include Arcellx and Tourmaline Bio, acquired b…
  biospace · 1mo ago
• STAT+: Doritos as farm-to-table snacks? Big Food, under duress, gets creative
  Doritos in the classic nacho cheese flavor have 27 ingredients, including not just familiar ones but also a number of additives and preservatives.
  stat · 1mo ago
• STAT+: Sanofi to lay off 229 workers in Mass., a year after $9.1B Blueprint Medicines acquisition
  Sanofi, one of the Massachusetts' largest pharmaceutical employers, will lay off more than 200 workers there a year after acquiring Blueprint Medicines.
  stat · 1mo ago